Rapamycin (AY-22,989), a new antifungal antibiotic. I. taxonomy of the producing streptomycete and isolation of the active principle

1.5kCitations
Citations of this article
657Readers
Mendeley users who have this article in their library.

Abstract

A streptomycete was isolated from an Easter Island soil sample and found to inhibit Candida albicans, Microsporum gypseum and Trichophyton granulosum. The antibioticproducing microorganism was characterized and identified as Streptomyces hygroscopicus. The antifungal principle was extracted with organic solvent from the mycelium, isolated in crystalline form and named rapamycin. Rapamycin is mainly active against Candida albicans; minimum inhibitory concentration against ten strains ranged from 0.02 to 0.2 μg/ml. Its apparent activity against Microsporum gypseum and Trichophyton granulosum is lower because of its instability in culture media on prolonged incubation required by these fungi. No activity was observed against gram-positive and gram-negative bacteria. Acute toxicity in mice is low. © 1975, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Vézina, C., & Kudelski, A. (1975). Rapamycin (AY-22,989), a new antifungal antibiotic. I. taxonomy of the producing streptomycete and isolation of the active principle. The Journal of Antibiotics, 28(10), 721–726. https://doi.org/10.7164/antibiotics.28.721

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free